硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
人 NOP2 抗体对
试剂盒

人 NOP2 抗体对

01AB02861

NOP2 nucleolar protein (NOP2) is a highly conserved S-adenosyl-L-methionine-dependent RNA methyltransferase that catalyzes the C5-methylation of cytosine 4447 in 28S rRNA. This modification is essential for efficient pre-rRNA processing and the biogenesis of the 60S ribosomal subunit. NOP2 also regulates ribosome assembly through non-catalytic interactions with box C/D snoRNAs, promoting the recruitment of U3 and U8 snoRNAs to pre-90S particles. Beyond its role in ribosome biogenesis, NOP2 is involved in the positive regulation of cell proliferation and p53-mediated signaling. Clinically, NOP2 is overexpressed in various malignancies, including high-grade serous ovarian cancer, where it acts as an oncogenic factor. It promotes tumor cell proliferation, migration, and invasion through m5C-dependent regulation of the cAMP pathway, and its high expression levels are significantly correlated with poor patient prognosis.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
NOP2
基因别名
NOL1; NSUN1
蛋白别名
NOP2 nucleolar protein; NOP2
UniProt
P46087
物种
Human

产品详情

靶点名称
NOP2
蛋白名称
NOP2 nucleolar protein
蛋白别名
28S rRNA; cytosine(4447)-C(5))-methyltransferase; Nucleolar protein 1; Nucleolar protein 2 homolog; Proliferating-cell nucleolar antigen p120; Proliferation-associated nucleolar protein p120
靶点基因名
NOP2
基因别名
NOL1; NSUN1
UniProt
P46087
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

NOP2 nucleolar protein (NOP2) is a highly conserved S-adenosyl-L-methionine-dependent RNA methyltransferase that catalyzes the C5-methylation of cytosine 4447 in 28S rRNA. This modification is essential for efficient pre-rRNA processing and the biogenesis of the 60S ribosomal subunit. NOP2 also regulates ribosome assembly through non-catalytic interactions with box C/D snoRNAs, promoting the recruitment of U3 and U8 snoRNAs to pre-90S particles. Beyond its role in ribosome biogenesis, NOP2 is involved in the positive regulation of cell proliferation and p53-mediated signaling. Clinically, NOP2 is overexpressed in various malignancies, including high-grade serous ovarian cancer, where it acts as an oncogenic factor. It promotes tumor cell proliferation, migration, and invasion through m5C-dependent regulation of the cAMP pathway, and its high expression levels are significantly correlated with poor patient prognosis.